Cancer

Inherited mutations in genes like BRCA1, BRCA2, TP53, and APC significantly increase cancer risk. These mutations impair the body's ability to repair DNA damage or regulate cell growth. Family history of cancer can indicate higher genetic predisposition.

Tobacco smoke contains over 70 known carcinogens that damage DNA in cells of the lungs, mouth, throat, and many other organs. Occupational exposure to asbestos, benzene, formaldehyde, and radiation also causes cellular mutations leading to cancer development.

Persistent infections like HPV (cervical cancer), Hepatitis B/C (liver cancer), and H. pylori (stomach cancer) cause chronic inflammation that promotes DNA damage. Chronic inflammatory conditions like ulcerative colitis also increase cancer risk in affected tissues.

Obesity, physical inactivity, excessive alcohol consumption, and poor diet create a pro-cancer environment through hormonal imbalances, oxidative stress, and chronic inflammation. These factors account for a substantial proportion of preventable cancers worldwide.

Ultraviolet radiation from sun exposure causes DNA mutations leading to skin cancers including melanoma. Ionizing radiation from medical imaging overuse, radon gas, and nuclear exposure damages cellular DNA. Environmental pollutants and endocrine disruptors also contribute to cancer development.

Surgical removal of tumors is often the first-line treatment for solid cancers that haven't widely spread. It aims to remove the entire tumor with clear margins and may be curative for early-stage cancers. Often combined with other treatments for comprehensive care.

Uses powerful drugs to kill rapidly dividing cancer cells throughout the body. Chemotherapy addresses cancers that have spread or are at high risk of spreading, and can be used before surgery to shrink tumors or after surgery to eliminate remaining cells.

Uses high-energy beams to destroy cancer cells and shrink tumors by damaging their DNA. It targets localized tumors and is used for cancers where surgery isn't feasible, or as adjuvant therapy after surgery to eliminate residual disease.

Harnesses the patient's immune system to recognize and attack cancer cells. Checkpoint inhibitors, CAR-T cell therapy, and other immunotherapies have revolutionized treatment for melanoma, lung cancer, and blood cancers, often producing durable responses in advanced disease.

Targeted drugs attack specific molecular changes in cancer cells, such as HER2 in breast cancer or BRAF in melanoma. Hormone therapies block estrogen or testosterone to treat hormone-receptor-positive breast and prostate cancers, reducing recurrence risk significantly.

Daily meditation and mindfulness practice can reduce cortisol levels and improve immune function in cancer patients. Studies show mindfulness-based stress reduction improves quality of life, sleep, and emotional well-being during cancer treatment. Practice 15-20 minutes daily.

Regular moderate physical activity like walking 30 minutes daily helps reduce cancer-related fatigue, improves mood, and supports immune function. Exercise addresses the deconditioning and depression that often accompany cancer treatment and may improve treatment outcomes.

Fresh ginger root steeped in hot water can help alleviate nausea associated with chemotherapy. Ginger contains gingerols and shogaols that have anti-emetic properties. Sip small amounts throughout the day, but consult your oncologist as ginger may interact with blood thinners.

Wearing a cooling cap during chemotherapy sessions constricts blood vessels in the scalp, reducing the amount of chemotherapy drugs reaching hair follicles. This simple physical intervention can significantly reduce hair loss during treatment, improving psychological well-being.

Acupuncture has evidence supporting its use for managing cancer-related pain, chemotherapy-induced nausea, and fatigue. Many cancer centers now offer integrative acupuncture as a complementary therapy. Ensure the practitioner is experienced with oncology patients and uses sterile techniques.

Rich in sulforaphane and indole-3-carbinol, these compounds help the body detoxify carcinogens and may inhibit cancer cell growth. Cruciferous vegetables also contain fiber and antioxidants that reduce oxidative stress and inflammation associated with cancer development.

Packed with anthocyanins, ellagic acid, and other polyphenols that have potent antioxidant and anti-inflammatory properties. Research shows these compounds can inhibit tumor growth, reduce angiogenesis, and protect DNA from oxidative damage.

Rich in omega-3 fatty acids EPA and DHA, which have anti-inflammatory properties that may help suppress tumor-promoting inflammation. Fatty fish also provides high-quality protein essential for maintaining muscle mass during cancer treatment.

Curcumin in turmeric has demonstrated anti-cancer properties in laboratory studies, including inhibiting cancer cell proliferation and reducing inflammation. Consuming turmeric with black pepper (piperine) increases curcumin absorption by up to 2000%.

Rich in lycopene, a powerful carotenoid antioxidant that has shown particular promise in reducing prostate cancer risk. Cooking tomatoes in olive oil significantly increases lycopene bioavailability. Tomatoes also provide vitamin C and other protective phytochemicals.

High in fiber, folate, and resistant starch, legumes feed beneficial gut bacteria that produce short-chain fatty acids with anti-cancer properties. Regular legume consumption is associated with reduced colorectal cancer risk and helps maintain healthy weight.

Contains epigallocatechin gallate (EGCG), a potent polyphenol that has shown anti-cancer effects in numerous studies by inhibiting tumor cell proliferation and promoting apoptosis. Regular green tea consumption is associated with reduced risk of several cancers in epidemiological studies.

Classified as Group 1 carcinogens by the WHO, processed meats contain nitrites and nitrates that form cancer-causing N-nitroso compounds in the body. Regular consumption significantly increases colorectal cancer risk, with each 50g daily portion raising risk by about 18%.

Cooking meat at very high temperatures produces heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs), both proven carcinogens. These compounds cause DNA mutations that can initiate cancer, particularly in the colon, stomach, and pancreas.

Alcohol is metabolized into acetaldehyde, a toxic compound that damages DNA and proteins. It increases risk of cancers of the mouth, throat, esophagus, liver, breast, and colon. Even moderate drinking raises breast cancer risk, and risk increases with amount consumed.

Regular consumption of sugar-sweetened beverages promotes obesity, insulin resistance, and chronic inflammation—all of which create a pro-cancer environment. High sugar intake leads to elevated insulin and insulin-like growth factor (IGF-1), which can promote tumor cell growth.

Foods with artificial additives, preservatives, emulsifiers, and highly refined ingredients are associated with increased cancer risk in large cohort studies. A 10% increase in ultra-processed food intake has been linked to a 12% increase in overall cancer risk, likely due to chemical additives and nutrient-poor profiles.

Found in some fried foods, margarine, and packaged snacks, trans fats promote systemic inflammation and oxidative stress. They disrupt normal cell membrane function and are associated with increased risk of several cancers, including breast and colorectal cancer.

High sodium intake damages the stomach lining, promoting chronic inflammation and increasing susceptibility to H. pylori infection. Traditionally salt-preserved and pickled foods are strongly associated with stomach cancer risk, particularly in East Asian populations.

Low vitamin D levels are associated with increased risk of colorectal, breast, and prostate cancers in observational studies. Evidence is moderate-to-strong for maintaining adequate levels (40-60 ng/mL). Typical dosage is 1000-4000 IU daily; excess can cause hypercalcemia, so blood levels should be monitored.

May help reduce cancer-related inflammation and cachexia (muscle wasting). Evidence is moderate for supportive care during treatment, with typical doses of 1-3 grams EPA+DHA daily. Caution with blood thinners as omega-3s have mild anticoagulant effects; consult oncologist before use.

Laboratory and early clinical studies show curcumin may inhibit cancer cell growth and enhance chemotherapy effectiveness. Evidence in humans is still limited but promising. Typical dosage is 500-2000 mg daily with piperine for absorption. May interact with chemotherapy drugs—always consult your oncologist.

Contain beta-glucans that may enhance immune function and complement conventional cancer treatment. Turkey tail (Trametes versicolor) extract PSK is approved as adjunct cancer therapy in Japan. Evidence is moderate; typical dose is 1-3 grams daily. Quality varies widely between products.

May help manage chemotherapy-related gastrointestinal side effects including diarrhea and mucositis. Evidence is moderate for specific strains like Lactobacillus and Saccharomyces boulardii. Avoid in severely immunocompromised patients as live bacteria could cause infection; consult oncologist first.

Research suggests melatonin may improve sleep quality during cancer treatment and potentially enhance chemotherapy effectiveness while reducing side effects. Evidence is moderate from multiple small trials. Typical dosage is 3-20 mg at bedtime. Generally well-tolerated but may interact with immunosuppressants.

Standardized EGCG extracts have shown anti-cancer properties in cell and animal studies, with some positive early human trials in prostate and breast cancer prevention. Evidence is limited but growing. Typical dose is 250-500 mg EGCG daily. High doses can cause liver toxicity; may interact with certain chemotherapies including bortezomib.